Rx Industry Should Support Imports To Block Other Price Controls – Attorney
Executive Summary
Drug manufacturers should support a legalized drug importation system because it is the most benign form of cost containment facing the industry, Mayer, Brown, Rowe & Maw Partner Alvin Lorman said